|
Volumn 847, Issue 2, 2007, Pages 142-152
|
The determination of gemcitabine and 2′-deoxycytidine in human plasma and tissue by APCI tandem mass spectrometry
|
Author keywords
Deoxycytidine; Difluorodeoxycytidine; Gemcitabine; HPLC; Mass spectrometry
|
Indexed keywords
ATMOSPHERIC PRESSURE CHEMICAL IONIZATION (APCI);
DEOXYCYTIDINES;
DIFLUORODEOXYURIDINES (DFDU);
GEMCITABINES;
HUMAN PLASMAS;
LIMIT OF QUANTITATION (LOQ);
MULTI REACTION MONITORING (+MRM) MODES;
LIQUID CHROMATOGRAPHY;
LIVING SYSTEMS STUDIES;
MASS SPECTROMETRY;
PRECIPITATION (CHEMICAL);
TISSUE;
PROTEINS;
15 N 3 DEOXYCYTIDINE;
ACETONITRILE;
DEOXYCYTIDINE;
FORMIC ACID;
GEMCITABINE;
RADIOPHARMACEUTICAL AGENT;
UNCLASSIFIED DRUG;
ACCURACY;
ARTICLE;
BLOOD ANALYSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DESORPTION;
DRUG BLOOD LEVEL;
DRUG DOSE ESCALATION;
ELUTION;
FREEZE DRYING;
HUMAN;
HUMAN TISSUE;
INFUSION;
LIQUID CHROMATOGRAPHY;
LIQUID LIQUID EXTRACTION;
MASS SPECTROMETRY;
PHASE 1 CLINICAL TRIAL;
PRECIPITATION;
PRIORITY JOURNAL;
TANDEM MASS SPECTROMETRY;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CLINICAL TRIALS, PHASE I;
DEOXYCYTIDINE;
HUMANS;
REPRODUCIBILITY OF RESULTS;
TANDEM MASS SPECTROMETRY;
TISSUE DISTRIBUTION;
|
EID: 33847255317
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchromb.2006.09.045 Document Type: Article |
Times cited : (48)
|
References (25)
|